Dental industry news: PDI launches new advanced skin antisepsis platform
ORANGEBURG, New York—PDI, a leader in infection prevention education, support, and products, has announced launch of a new Advanced Skin Antisepsis platform, PDI Prevantics.
With the platform, the company is investing in innovations that will provide efficient and advanced evidence-based solutions for helping prevent health-care-associated infections. These innovations will include new formulations, applications, and delivery systems.
“The introduction of the new PDI Prevantics brand positions us toward developing a platform that supports a broader range of advanced skin antisepsis solutions and builds on our commitment to empower health-care professionals to Be the Difference in reducing infections and controlling associated costs,” said Dan Marsh, executive vice president for PDI.
The PDI Prevantics platform will house future and current advanced skin antiseptics, starting with the existing Chlorascrub line. As a preoperative and preinjection skin antiseptic with a 3.15% chlorhexidine gluconate and 70% isopropyl alcohol, Chlorascrub has proven to improve outcomes and reduce health-care costs.
This helps make it a fit for the new PDI Prevantics platform. Product packaging reflecting the new name will transition in the market late January through early February 2013. The formulation, delivery format, and ordering procedures for the product will remain the same.
PDI helps reduce preventable infections, control health-care costs, and ultimately save lives by delivering a range of evidence-based, market-leading environmental hygiene and patient care solutions.
For more informaiton, visit www.pdipdi.com/healthcare.
To comment on this topic, go to http://community.pennwelldentalgroup.com.
